APA (7th ed.) Citation

Helal, M. M., Almosilhy, N. A., Abo-Elnour, D. E., Jaffal, R. S. Y., Allam, E. G., Almosilhy, M. A., . . . Meshref, M. (2026). Targeting metabolic dysfunction in amyotrophic lateral sclerosis: Therapeutic potential of GLP-1 receptor agonists. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 27(5/6), 513. https://doi.org/10.1080/21678421.2026.2627901

Chicago Style (17th ed.) Citation

Helal, Mohamed Mohsen, Nereen A. Almosilhy, Dina Essam Abo-Elnour, Rana Suhail Younis Jaffal, Eman Gomaa Allam, Mohammed A. Almosilhy, Suhel F. Batarseh, and Mostafa Meshref. "Targeting Metabolic Dysfunction in Amyotrophic Lateral Sclerosis: Therapeutic Potential of GLP-1 Receptor Agonists." Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration 27, no. 5/6 (2026): 513. https://doi.org/10.1080/21678421.2026.2627901.

MLA (9th ed.) Citation

Helal, Mohamed Mohsen, et al. "Targeting Metabolic Dysfunction in Amyotrophic Lateral Sclerosis: Therapeutic Potential of GLP-1 Receptor Agonists." Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, vol. 27, no. 5/6, 2026, p. 513, https://doi.org/10.1080/21678421.2026.2627901.